AB | BC | MB | NB | NL | NS | NT | ON | PE | QC | SK | YT
Search National Drug Schedules Member Login

What's New

National Drug Scheduling Advisory Committee Meeting June 6, 2016

The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for Monday, June 6, 2016.
[> More]

NAPRA Executive Director / Directeur général de l'ANORP

NAPRA Executive Director

Directeur général de l'ANORP

National Drug Schedules: Final Recommendations on modified-release ibuprofen, esomeprazole and fluticasone propionate nasal spray

The Interim Recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on March 16, 2016, subsequent to their meeting of March 8, 2016, were finalized effective April 15, 2016.
[> More]

Pharmacy Technician Bridging Education Program-Course and PLAR exam schedules

Please note, this section will be updated periodically as the information becomes available.


  Reminder: Courses and PLAR exams available in both English and French

    NOTE: Selkirk College registration deadline for all English and French courses beginning in April 2016 is April 7, 2016


        Rappel :  Les cours et les examens ERA sont offerts en français et en anglais

  REMARQUE :  La date limite pour l’inscription aux cours (anglais et français) débutant en avril 2016 au collège Selkirk est le 7 avril 2016 

Registration deadlines for all institutions are available on the Course and PLAR Schedules page.

Registration for all courses is conducted directly with the educational institution offering the program.

Health Product Risk Communication

BCR-ABL Tyrosine Kinase Inhibitors [GLEEVEC (imatinib mesylate), TASIGNA (nilotinib), BOSULIF (bosutinib), SPRYCEL (dasatinib), ICLUSIG (ponatinib hydrochloride)] - Risk of Hepatitis B Reactivation - Novartis Pharmaceuticals Canada Inc., Pfizer Canada Inc. Canada, Bristol-Myers Squibb, ARIAD Pharmaceuticals, Inc.

Cases of reactivation of hepatitis B virus (HBV) have occurred in patients who are chronic carriers of HBV after they received BCR-ABL tyrosine kinase inhibitors. Some cases of HBV reactivation resulted in acute hepatic failure or fulminant hepatitis leading to liver transplantation or a fatal outcome.

Health Canada Health Product Risk Communication

Health Product Risk Communication

ZYDELIG (idelalisib) - Increased Risk of Fatal and Serious Infections - Gilead Sciences Canada, Inc.

Decreased overall survival and an increased risk of serious adverse events (mostly infections) were observed in patients receiving ZYDELIG compared to the control groups in clinical trials.

Health Product Risk Communication


Unauthorized products seized at Calgary retailer may pose serious health risks

Health Canada seized seventeen unauthorized health products from the retailer, Matrioshka Russian Delicatessen, in Calgary, Alberta. Two unauthorized products were labelled with prescription drug ingredients (captopril and sulfanilamide). Products that contain prescription drug ingredients should only be taken under the supervision of a health professional because they are used to treat specific diseases, and may cause serious side effects.

Health Canada Advisory

Health Product Risk Communication

Cook Catheters with Beacon Tip Technology – Recall Due to Degradation of Catheter Tip - Cook (Canada) Inc.

Cook Catheters with Beacon Tip technology have been recalled due to polymer degradation of the catheter tip, which could result in tip fracture and/or separation. Health Canada is aware that this may cause a shortage issue. To obtain information on other products that can be used as alternatives, healthcare professionals should contact Cook Medical directly.

Health Canada Health Product Risk Communication

Health Product InfoWatch - April 2016

The April issue of the Health Product InfoWatch published by Health Canada is now available.
[> More]

Announcement - Executive Director, NAPRA

Letter to stakeholders



Gateway for international
Portail pour pharmaciens
formés à l’étranger




National Pharmacy Technician Bridging Education Program

Students and educational institutions can find more information about NAPRA's newest program.

NDSAC Drug Scheduling Applications

Find information about the NDSAC process and how to prepare scheduling applications.